(Q33822798)

29 July 2017

1 reference

title

Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections (English)

1 reference

29 July 2017

Jones TC

1

1 reference

29 July 2017

1 August 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35 Suppl 3

1 reference

29 July 2017

S8-10

1 reference

Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900084-2

7 January 2021

10.1016/S0959-8049(99)00084-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10645213